Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can a hyaluronic acid injection really boost skin health? new study aims to find out

NCT ID NCT07542132

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Aug 27, 2026 · Updated 2 times

Summary

This study will test whether injecting hyaluronic acid into the skin causes measurable changes in skin health markers and structure. Twenty healthy adults will receive one injection, one needle poke without product, and one untouched area for comparison. Small skin samples will be taken to analyze biological changes over six weeks.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
hyaluronic acid
What this could lead to
If successful, this could provide scientific evidence for how hyaluronic acid improves skin health at a biological level.
What could go wrong
This is a very small, early-stage study with only 20 participants and no direct health benefits. Results may not apply to the general population.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 20 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Oct 2026

An estimate. Start dates often move.

Expected to finish

May 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 50 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion criteria: * Informed Consent signed by the subject * Healthy adult volunteers aged 18 to 50 years at the time of inclusion * Ability and willingness to comply with all study procedures and visits as required by the protocol. Exclusion criteria: * Pregnant or breastfeeding women, or women unwilling to use an effective method of contraception, as the use of the investigational medical device is contraindicated according to the Instructions for Use (IFU) * Known hypersensitivity to any of the product ingredients, as well as fructose intolerance. * Any skin disease or systemic disease that, in the opinion of the investigator, may affect the treatment area or interfere with study assessments. * Presence of any skin alteration at the test sites, including but not limited to scars, tattoos, or other visible skin lesions. * History of hypertrophic scars or keloid formation or a similar abnormal wound healing. * Presence of terminal hairs at the designated test sites. * Current use of any medication or treatment that, in the judgment of the investigator, may interfere with the interpretation of study results or pose a safety concern. * Body Mass Index (BMI) \> 36 kg/m². * Any medical, psychological, psychiatric, or cognitive condition, including drug or alcohol abuse, language barriers, or other circumstances that, in the opinion of the investigator, may impair the subject's ability to understand the study information, comply with the investigation procedures, or complete the investigation. * Participation in another clinical investigation involving an investigational medicinal product or medical device within the 30 days prior to enrolment. * Previous enrolment in the current investigation. * Enrolment of the principal investigator, sub-investigators, their family members, employees, or other dependent persons.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Skin health are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Geneva University Hospitals (HUG)

    Geneva, 1201, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.